The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A descriptive study on the treatment and outcomes of patients with platinum-sensitive, advanced, BRCA- or PALB2-related pancreatic cancer who have progressed on rucaparib.
 
Timothy J Brown
No Relationships to Disclose
 
Mark H. O'Hara
Consulting or Advisory Role - Geneos; Natera
Research Funding - Arcus Biosciences; Bristol-Myers Squibb; Celldex; Lilly; Natera; Parker Institute for Cancer Immunotherapy
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Ursina R. Teitelbaum
No Relationships to Disclose
 
Thomas Benjamin Karasic
Honoraria - AstraZeneca/MedImmune; Exelixis; Incyte; Ipsen; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); H3 Biomedicine (Inst); Lilly (Inst); Sirtex Medical (Inst); Syndax (Inst); Taiho Pharmaceutical (Inst); Tempest Therapeutics (Inst); Xencor (Inst)
 
Charles John Schneider
No Relationships to Disclose
 
Natallia Izgur
No Relationships to Disclose
 
Katherine L. Nathanson
Employment - Janssen Oncology
 
Susan M. Domchek
Honoraria - AstraZeneca; GlaxoSmithKline
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst)
 
Kim Anna Reiss
Honoraria - MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Carisma Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology; GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Tesaro (Inst)